Condition

Supine Hypertension

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting3

Common interventions10

Lead sponsors shown2

Clinical trials

4 shown

CPAP for the Treatment of Supine HypertensionNCT05489575 · 2022-06-23

RECRUITING

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic FailureNCT04502225 · 2020-08-21

RECRUITING

Treatment of Supine Hypertension in Autonomic Failure (CPAP)NCT03312556 · 2017-09-21

RECRUITING

Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in AutonomicNCT02726711 · 2016-04-01

ACTIVE_NOT_RECRUITING

Common interventions

PlaceboDRUG2 Active CPAPDEVICE1 continuous positive airway pressure (CPAP)DEVICE1 Elevated trunkOTHER1 Elevated Trunk - In homeOTHER1 Sham CPAPDEVICE1 Sleeping in a head-up tilt (HUT) positionOTHER1 TiltOTHER1 Tilt - In homeOTHER1 TrimethaphanDRUG1

Leading sponsors

Vanderbilt University Medical Center 3 Vanderbilt University 1

Trial status mix

RECRUITING3

ACTIVE_NOT_RECRUITING1

Phase mix

NA3

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.